AAAAAA

   
Results: 1-25 | 26-31
Results: 1-25/31
DIFFERENCES IN REVERSE-TRANSCRIPTASE ACTIVITY VERSUS P24 ANTIGEN-DETECTION IN CELL-CULTURE, WHEN COMPARING A HOMOGENEOUS GROUP OF HIV TYPE-1 SUBTYPE-B VIRUSES WITH A HETEROGENEOUS GROUP OF DIVERGENT STRAINS
Authors: CORRIGAN GE ALKHALILI L MALMSTEN A THORSTENSSON R FENYO EM KALLANDER CFR GRONOWITZ JS
Citation: Ge. Corrigan et al., DIFFERENCES IN REVERSE-TRANSCRIPTASE ACTIVITY VERSUS P24 ANTIGEN-DETECTION IN CELL-CULTURE, WHEN COMPARING A HOMOGENEOUS GROUP OF HIV TYPE-1 SUBTYPE-B VIRUSES WITH A HETEROGENEOUS GROUP OF DIVERGENT STRAINS, AIDS research and human retroviruses, 14(4), 1998, pp. 347-352
OPTIMIZATION OF POLYMERASE-CHAIN-REACTION FOR DETECTION OF HIV TYPE-2DNA
Authors: WALTHER L GRANKVIST O MIRZAI B DASILVA Z FREDLUND H BIBERFELD G THORSTENSSON R
Citation: L. Walther et al., OPTIMIZATION OF POLYMERASE-CHAIN-REACTION FOR DETECTION OF HIV TYPE-2DNA, AIDS research and human retroviruses, 14(13), 1998, pp. 1151-1156
LIVE ATTENUATED SIMIAN IMMUNODEFICIENCY VIRUS (SIV)MAC IN MACAQUES CAN INDUCE PROTECTION AGAINST MUCOSAL INFECTION WITH SIVSM
Authors: NILSSON C MAKITALO B THORSTENSSON R NORLEY S BINNINGERSCHINZEL D CRANAGE M RUD E BIBERFELD G PUTKONEN P
Citation: C. Nilsson et al., LIVE ATTENUATED SIMIAN IMMUNODEFICIENCY VIRUS (SIV)MAC IN MACAQUES CAN INDUCE PROTECTION AGAINST MUCOSAL INFECTION WITH SIVSM, AIDS, 12(17), 1998, pp. 2261-2270
REDUCTION OF THE DIAGNOSTIC WINDOW WITH A NEW COMBINED P24 ANTIGEN AND HUMAN-IMMUNODEFICIENCY-VIRUS ANTIBODY SCREENING ASSAY
Authors: GURTLER L MUHLBACHER A MICHL U HOFMANN H PAGGI GG BOSSI V THORSTENSSON R VILLAESCUSA RG EIRAS A HERNANDEZ JM MELCHIOR W DONIE F WEBER B
Citation: L. Gurtler et al., REDUCTION OF THE DIAGNOSTIC WINDOW WITH A NEW COMBINED P24 ANTIGEN AND HUMAN-IMMUNODEFICIENCY-VIRUS ANTIBODY SCREENING ASSAY, Journal of virological methods, 75(1), 1998, pp. 27-38
EVALUATION OF 14 COMMERCIAL HIV-1 HIV-2 ANTIBODY-ASSAYS USING SERUM PANELS OF DIFFERENT GEOGRAPHICAL ORIGIN AND CLINICAL STAGE INCLUDING A UNIQUE SEROCONVERSION PANEL/
Authors: THORSTENSSON R ANDERSSON S LINDBACK S DIAS F MHALU F GAINES H BIBERFELD G
Citation: R. Thorstensson et al., EVALUATION OF 14 COMMERCIAL HIV-1 HIV-2 ANTIBODY-ASSAYS USING SERUM PANELS OF DIFFERENT GEOGRAPHICAL ORIGIN AND CLINICAL STAGE INCLUDING A UNIQUE SEROCONVERSION PANEL/, Journal of virological methods, 70(2), 1998, pp. 139-151
IMMUNE-RESPONSES BUT NO PROTECTION AGAINST SHIV BY GENE-GUN DELIVERY OF HIV-1 DNA FOLLOWED BY RECOMBINANT SUBUNIT PROTEIN BOOSTS
Authors: PUTKONEN P QUESADAROLANDER M LEANDERSSON AC SCHWARTZ S THORSTENSSON R OKUDA K WAHREN B HINKULA J
Citation: P. Putkonen et al., IMMUNE-RESPONSES BUT NO PROTECTION AGAINST SHIV BY GENE-GUN DELIVERY OF HIV-1 DNA FOLLOWED BY RECOMBINANT SUBUNIT PROTEIN BOOSTS, Virology (New York, N.Y. Print), 250(2), 1998, pp. 293-301
OUTCOME OF IMMUNIZATION OF CYNOMOLGUS MONKEYS WITH RECOMBINANT SEMLIKI-FOREST-VIRUS ENCODING HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE PROTEIN AND CHALLENGE WITH A HIGH-DOSE OF SHIV-4 VIRUS
Authors: BERGLUND P QUESADAROLANDER M PUTKONEN P BIBERFELD G THORSTENSSON R LILJESTROM P
Citation: P. Berglund et al., OUTCOME OF IMMUNIZATION OF CYNOMOLGUS MONKEYS WITH RECOMBINANT SEMLIKI-FOREST-VIRUS ENCODING HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE PROTEIN AND CHALLENGE WITH A HIGH-DOSE OF SHIV-4 VIRUS, AIDS research and human retroviruses, 13(17), 1997, pp. 1487-1495
MEASUREMENT OF LEVELS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE (RT) AND RT ACTIVITY-BLOCKING ANTIBODY IN HUMAN SERUM BYA NEW STANDARDIZED COLORIMETRIC ASSAY
Authors: AWAD RJK CORRIGAN GE EKSTRAND DHL THORSTENSSON R KALLANDER CFR GRONOWITZ JS
Citation: Rjk. Awad et al., MEASUREMENT OF LEVELS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE (RT) AND RT ACTIVITY-BLOCKING ANTIBODY IN HUMAN SERUM BYA NEW STANDARDIZED COLORIMETRIC ASSAY, Journal of clinical microbiology, 35(5), 1997, pp. 1080-1089
PROTECTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 2-EXPOSED SERONEGATIVE MACAQUES FROM MUCOSAL SIMIAN IMMUNODEFICIENCY VIRUS TRANSMISSION
Authors: PUTKONEN P MAKITALO B BOTTIGER D BIBERFELD G THORSTENSSON R
Citation: P. Putkonen et al., PROTECTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 2-EXPOSED SERONEGATIVE MACAQUES FROM MUCOSAL SIMIAN IMMUNODEFICIENCY VIRUS TRANSMISSION, Journal of virology, 71(7), 1997, pp. 4981-4984
KONZO, AN EPIDEMIC SPASTIC PARAPARESIS IN AFRICA, IS NOT ASSOCIATED WITH ANTIBODIES TO HTLV-I, HIV, OR HIV GAG-ENCODED PROTEINS
Authors: TYLLESKAR T BANEA M BOTTIGER B THORSTENSSON R BIBERFELD G ROSLING H
Citation: T. Tylleskar et al., KONZO, AN EPIDEMIC SPASTIC PARAPARESIS IN AFRICA, IS NOT ASSOCIATED WITH ANTIBODIES TO HTLV-I, HIV, OR HIV GAG-ENCODED PROTEINS, Journal of acquired immune deficiency syndromes and human retrovirology, 12(3), 1996, pp. 317-318
PROTECTION AGAINST HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 AND SIMIAN IMMUNODEFICIENCY VIRUS IN MACAQUES VACCINATED AGAINST HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2
Authors: BIBERFELD G THORSTENSSON R PUTKONEN P
Citation: G. Biberfeld et al., PROTECTION AGAINST HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 AND SIMIAN IMMUNODEFICIENCY VIRUS IN MACAQUES VACCINATED AGAINST HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2, AIDS research and human retroviruses, 12(5), 1996, pp. 443-446
NESTED POLYMERASE CHAIN-REACTION PRIMERS THAT DISTINGUISH BETWEEN SIVSM AND HIV TYPE-2
Authors: WALTHER L GRANKVIST O PUTKONEN P BIBERFELD G THORSTENSSON R
Citation: L. Walther et al., NESTED POLYMERASE CHAIN-REACTION PRIMERS THAT DISTINGUISH BETWEEN SIVSM AND HIV TYPE-2, AIDS research and human retroviruses, 12(12), 1996, pp. 1077-1079
PROTECTION AGAINST MUCOSAL SIVSM CHALLENGE IN MACAQUES INFECTED WITH A CHIMERIC SIV THAT EXPRESSES HIV TYPE-1 ENVELOPE
Authors: QUESADAROLANDER M MAKITALO B THORSTENSSON R ZHANG YJ CASTANOSVELEZ E BIBERFELD G PUTKONEN P
Citation: M. Quesadarolander et al., PROTECTION AGAINST MUCOSAL SIVSM CHALLENGE IN MACAQUES INFECTED WITH A CHIMERIC SIV THAT EXPRESSES HIV TYPE-1 ENVELOPE, AIDS research and human retroviruses, 12(11), 1996, pp. 993-999
VISCERAL LEISHMANIASIS IN SOMALIA - SIGNIFICANCE OF IGG SUBCLASSES AND OF IGE RESPONSE
Authors: SHIDDO SA HULDT G NILSSON LA OUCHTERLONY O THORSTENSSON R
Citation: Sa. Shiddo et al., VISCERAL LEISHMANIASIS IN SOMALIA - SIGNIFICANCE OF IGG SUBCLASSES AND OF IGE RESPONSE, Immunology letters, 50(1-2), 1996, pp. 87-93
IMMUNOGENICITY AND PROTECTIVE EFFICACY OF A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 RECOMBINANT CANARYPOX (ALVAC) VACCINE CANDIDATE IN CYNOMOLGUS MONKEYS
Authors: ANDERSSON S MAKITALO B THORSTENSSON R FRANCHINI G TARTAGLIA J LIMBACH K PAOLETTI E PUTKONEN P BIBERFELD G
Citation: S. Andersson et al., IMMUNOGENICITY AND PROTECTIVE EFFICACY OF A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 RECOMBINANT CANARYPOX (ALVAC) VACCINE CANDIDATE IN CYNOMOLGUS MONKEYS, The Journal of infectious diseases, 174(5), 1996, pp. 977-985
LONG-TERM PROTECTION AGAINST SIV-INDUCED DISEASE IN MACAQUES VACCINATED WITH A LIVE ATTENUATED HIV-2 VACCINE
Authors: PUTKONEN P WALTHER L ZHANG YJ LI SL NILSSON C ALBERT J BIBERFELD P THORSTENSSON R BIBERFELD G
Citation: P. Putkonen et al., LONG-TERM PROTECTION AGAINST SIV-INDUCED DISEASE IN MACAQUES VACCINATED WITH A LIVE ATTENUATED HIV-2 VACCINE, Nature medicine, 1(9), 1995, pp. 914-918
LARGE-SCALE EVALUATION OF AN ALTERNATIVE STRATEGY FOR CONFIRMATION OFHIV ANTIBODIES
Authors: THORSTENSSON R GAINES H BIBERFELD G
Citation: R. Thorstensson et al., LARGE-SCALE EVALUATION OF AN ALTERNATIVE STRATEGY FOR CONFIRMATION OFHIV ANTIBODIES, Clinical and diagnostic virology, 4(1), 1995, pp. 15-25
EVALUATION OF HIV-1 HIV-2 IMMUNOBLOTS FOR DETECTION OF HIV-2 ANTIBODIES
Authors: WALTHER L PUTKONEN P DIAS F BIBERFELD G THORSTENSSON R
Citation: L. Walther et al., EVALUATION OF HIV-1 HIV-2 IMMUNOBLOTS FOR DETECTION OF HIV-2 ANTIBODIES, Clinical and diagnostic virology, 4(1), 1995, pp. 67-79
PROTECTIVE IMMUNITY IN CYNOMOLGUS MONKEYS PREEXPOSED TO SUBINFECTIOUSDOSES OF SIVSM OR HIV-2
Authors: BIBERFELD G MAKITALO B PUTKONEN P BOTTIGER D RUD E THORSTENSSON R
Citation: G. Biberfeld et al., PROTECTIVE IMMUNITY IN CYNOMOLGUS MONKEYS PREEXPOSED TO SUBINFECTIOUSDOSES OF SIVSM OR HIV-2, AIDS research and human retroviruses, 11, 1995, pp. 137-137
VIRUS-SPECIFIC IMMUNITY IN CYNOMOLGUS MONKEYS EXPOSED TO A LOW-DOSE OF SIVSM
Authors: THORSTENSSON R MAKITALO B BOTTIGER D RUD E BIBERFELD G PUTKONEN P
Citation: R. Thorstensson et al., VIRUS-SPECIFIC IMMUNITY IN CYNOMOLGUS MONKEYS EXPOSED TO A LOW-DOSE OF SIVSM, Journal of cellular biochemistry, 1995, pp. 227-227
VISCERAL LEISHMANIASIS IN SOMALIA - CIRCULATING ANTIBODIES AS MEASURED BY DAT, IMMUNOFLUORESCENCE AND ELISA
Authors: SHIDDO SA MOHAMED AA HULDT C LOFTENIUS A NILSSON LA JONSSON J OUCHTERLONY O THORSTENSSON R
Citation: Sa. Shiddo et al., VISCERAL LEISHMANIASIS IN SOMALIA - CIRCULATING ANTIBODIES AS MEASURED BY DAT, IMMUNOFLUORESCENCE AND ELISA, Tropical and geographical medicine, 47(2), 1995, pp. 68-73
HTLV INFECTIONS AMONG SWEDISH INTRAVENOUS-DRUG-USERS IN 1992
Authors: ANDERSSON S KROOK A KALL K JULANDER I THORSTENSSON R BIBERFELD G
Citation: S. Andersson et al., HTLV INFECTIONS AMONG SWEDISH INTRAVENOUS-DRUG-USERS IN 1992, Scandinavian journal of infectious diseases, 27(6), 1995, pp. 547-550
VISCERAL LEISHMANIASIS IN SOMALIA - PREVALENCE OF MARKERS OF INFECTION AND DISEASE MANIFESTATIONS IN A VILLAGE IN AN ENDEMIC AREA
Authors: SHIDDO SA MOHAMED AA AKUFFO HO MOHAMUD KA HERZI AA MOHAMED HH HULDT G NILSSON LA OUCHTERLONY O THORSTENSSON R
Citation: Sa. Shiddo et al., VISCERAL LEISHMANIASIS IN SOMALIA - PREVALENCE OF MARKERS OF INFECTION AND DISEASE MANIFESTATIONS IN A VILLAGE IN AN ENDEMIC AREA, Transactions of the Royal Society of Tropical Medicine and Hygiene, 89(4), 1995, pp. 361-365
VISCERAL LEISHMANIASIS IN SOMALIA - PREVALENCE OF LEISHMANIN-POSITIVEAND SEROPOSITIVE INHABITANTS IN AN ENDEMIC AREA
Authors: SHIDDO SA AKUFFO HO MOHAMED AA HULDT G NILSSON LA OUCHTERLONY O THORSTENSSON R
Citation: Sa. Shiddo et al., VISCERAL LEISHMANIASIS IN SOMALIA - PREVALENCE OF LEISHMANIN-POSITIVEAND SEROPOSITIVE INHABITANTS IN AN ENDEMIC AREA, Transactions of the Royal Society of Tropical Medicine and Hygiene, 89(1), 1995, pp. 21-24
LONG-STANDING PROTECTION OF MACAQUES AGAINST CELL-FREE HIV-2 WITH A HIV-2 ISCOM VACCINE
Authors: PUTKONEN P BJORLING E AKERBLOM L THORSTENSSON R LOVGREN K BENTHIN L CHIODI F MOREIN B BIBERFELD G NORRBY E WIGZELL H
Citation: P. Putkonen et al., LONG-STANDING PROTECTION OF MACAQUES AGAINST CELL-FREE HIV-2 WITH A HIV-2 ISCOM VACCINE, Journal of acquired immune deficiency syndromes, 7(6), 1994, pp. 551-559
Risultati: 1-25 | 26-31